scholarly journals Escherichia coli (STEC) serotype O104 outbreak causing haemolytic syndrome (HUS) in Germany and France

2011 ◽  
Vol 5 (06) ◽  
pp. 437-440 ◽  
Author(s):  
Salvatore Rubino ◽  
Piero Cappuccinelli ◽  
David J Kelvin

At the beginning of May an outbreak of bloody diarrhoea and haemolytic uraemic syndrome (HUS) began in Germany. During the succeeding months following the initial outbreak in Germany, thousands of infections occurred resulting in 877 cases of haemolytic uraemic syndrome (HUS) with 32 deaths and 3,043 cases of enterohaemorrhagic Escherichia coli (EHEC) with 16 deaths

The Lancet ◽  
1998 ◽  
Vol 352 (9128) ◽  
pp. 625-626 ◽  
Author(s):  
Yves Germani ◽  
Patrick Cunin ◽  
Etienne Tedjouka ◽  
Choua bou Ncharre ◽  
Jacques Morvan ◽  
...  

Author(s):  
Onengiyeofori Ibama ◽  
Edna O. Ibegbulem ◽  
Donatus Onwuli ◽  
Adline Ben-Chioma

Consumption of foods, water, vegetables, fruits, undercooked/ground/raw meat, unpasteurized milk or milk products contaminated with the bacterium strain Escherichia coli 0157:H7 has become a serious public health concern. This strain naturally inhabits the digestive tract of healthy cattle, and is released into the environment through the faeces of the animal. This strain cause haemorrhagic enterocolitis or gastroenteritis, and then haemolytic uraemic syndrome (HUS). HUS is a disorder characterised by haemolytic anaemia, low platelet count and acute kidney failure, and this disorder is a consequence of the production and action of Shiga-like toxin produced mainly by this bacterial strain (accounting for 90 percent of all cases), and occurs mainly in children less than five (5) years of age, but also occurs in the elderly. After infection with this bacterial strain, the disorder begins with intestinal perforation and ulceration leading to bloody diarrhoea, and consequently acute kidney injury, thrombocytopenia and microangiopathic haemolytic anaemia. In conjunction with clinical manifestations, several laboratory investigations (haematological, biochemical and microbiological assays) are implicated in the diagnosis of HUS. There is currently no specific treatment for HUS; however, supportive care (such as treatment of hypertension, fluid and electrolyte imbalance, haemodialysis, blood transfusion, etc) happens to be the only ameliorative measure for this disorder.


2011 ◽  
Vol 16 (26) ◽  
Author(s):  
G Gault ◽  
F X Weill ◽  
P Mariani-Kurkdjian ◽  
N Jourdan-da Silva ◽  
L King ◽  
...  

Binary file ES_Abstracts_Final_ECDC.txt matches


1989 ◽  
Vol 102 (3) ◽  
pp. 439-445 ◽  
Author(s):  
P. A. Chapman ◽  
D. J. Wright ◽  
P. Norman

SUMMARYDuring 1986 and 1987, faecal samples from patients with haemorrhagie colitis (HC) or haemolytic-uraemic syndrome (HUS) were examined for evidence of infection by verotoxin-producingEscherichia coli(VTEC). During the 2-year period VTEC infections were found in 31 (78%) of 40 patients initially presenting with HC, and in 5 (63%) of 8 patients initially presenting with HUS, VTEC were found in only 2 (0·9%) of 229 age and sex matched control patients with acute non-bloody diarrhoea. All but one VTEC belonged toE. coliserogroup O 157. During 1987 this serogroup was isolated from 2 (1%) of 207 samples of faeces taken from cattle arriving at a Sheffield abattoir, indicating a possible source of these infections for man. We are unaware of previous reports of isolation of this organism from cattle in England.


2011 ◽  
Vol 16 (22) ◽  
Author(s):  
M Askar ◽  
M S Faber ◽  
C Frank ◽  
H Bernard ◽  
A Gilsdorf ◽  
...  

Since early May 2011, a large outbreak of haemolytic uraemic syndrome (HUS) and bloody diarrhoea related to infections with Shiga toxin-producing Escherichia coli (STEC) has been observed in Germany. The outbreak is focused in the north, but cases have been reported from all German states and other countries. Since our report last week, the number of HUS cases has increased to 470 and STEC serotype O104 has been confirmed in many cases.


2013 ◽  
Vol 127 (3) ◽  
pp. 306-310
Author(s):  
S B Minami ◽  
H Takegoshi ◽  
Y Shinjo ◽  
K Kaga

AbstractObjectives:To describe two cases of profound hearing loss secondary to enterohaemorrhagic Escherichia coli infection, and to report the efficacy of subsequent cochlear implantation.Results:The first case was a four-year-old girl admitted to hospital with Escherichia coli O157 infection and haemolytic uraemic syndrome. Mild hearing loss was confirmed five months after discharge, progressing to profound loss three months later. At the age of seven years, she underwent cochlear implantation, with remarkable improvement in speech perception and production. The second case was a three-year-old boy admitted with haemolytic uraemic syndrome caused by Escherichia coli O111 infection. One year after disease onset, profound hearing loss was confirmed. Cochlear implantation at the age of five years produced significant recovery of auditory function.Conclusion:This study represents the first published report of secondary hearing loss after recovery from haemolytic uraemic syndrome caused by enterohaemorrhagic Escherichia coli. It indicates that cochlear implantation can restore hearing function in such patients.


Sign in / Sign up

Export Citation Format

Share Document